Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV (TCMAcuPilot)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00826345|
Recruitment Status : Completed
First Posted : January 22, 2009
Last Update Posted : June 22, 2012
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Neuropathy HIV AIDS HIV Infections||Other: Acupuncture / Moxibustion Other: Acupuncture/Moxibustion||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Patient-Oriented TCM Intervention for DSP in HIV: A Pilot Study|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||June 2009|
|Actual Study Completion Date :||June 2009|
Diagnostic Acupuncturists assessments will inform acupuncture/moxibustion treatment prescriptions for persons with HIV/AIDS experiencing distal peripheral neuropathy. This protocol is tailored specifically for the subject's unique diagnosis according to the symptoms being reported at each diagnostic acupuncture (DA) session.
Other: Acupuncture / Moxibustion
Acupuncture/Moxibustion points will be administered per point prescription.
Placebo Comparator: Placebo Acupuncture / Moxibustion
Sham/placebo Arm: Points will be administered away from the classic/traditional true point location.
Sham/Placebo Acupuncture/Moxibustion - Not active
- Symptom diary Gracely Pain Scale [ Time Frame: Baseline, Weekly and Follow-up visits ]
- Subjective Peripheral Neuropathy Screen (SPNS) Clinical Global Impression Scale Neurological Assessment Form [ Time Frame: Baseline, weekly and follow-up visits ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00826345
|United States, New York|
|New York, New York, United States, 10032|
|Principal Investigator:||Joyce K Anastasi, PhD||Columbia University|